The eye within the framework of human senescence: Biological decline and morbidity

Ophthalmic Research

Volumn 30, Issue 2, 1998, Pages 59-73

  Weale, Robert ^a,b  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Biological functions; Blindness; Cataract; Eye disease; Mortality

Indexed keywords

BLINDNESS; CATARACT; EYE; EYE DISEASE; HUMAN; LIFE EXPECTANCY; MORBIDITY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK ASSESSMENT; SENESCENCE; THEORY;

AGING; BLINDNESS; CATARACT; HUMANS; LENS NUCLEUS, CRYSTALLINE; MACULAR DEGENERATION; MORBIDITY; RISK FACTORS;

EID: 0031891784     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055456     Document Type: Review

References (76)

1. Shock NW: Indices of functional age; in Danon D, Shock NW, Marois M (eds): 'Aging: A Challenge to Science and Society. Oxford, Oxford University Press, 1981.
2. Weale RA: Have human biological functions evolved in support of a life-span? Mech Ageing Dev 1993; 69:65-77.
3. Weale RA: Human sensory functions and longevity Arch Geriatr Gerontol 1994;18:215-225.
4. Reading VM, Weale RA: A new analysis of United Nations mortality characteristics. Mech Ageing Dev 1991;57:25-48.
5. Faal H, Minassian DC, Sowa S, Foster A: National survey of blindness and low vision in the Gambia - Results. Br J Ophthalmol 1989, 73:82-87.
6. Martin GM, Bryant EM: Genetics of aging and disease models; in Terry RD (ed): Aging and the Brain. New York, Raven Press, 1988, chap 1.
7. Armaly M: Drug Mechanisms in Glaucoma. London, Churchill, 1966.
8. Jagger C, Lindsay J: The epidemiology of senile dementia; in Burns A (ed): Ageing and Dementia: A Methodological Approach. London, Arnold, 1993.
9. Diabetic Association: Diabetes in the UK (priv comm), 1995, pp 4-30.
10. Gibson JM, Rosenthal AR, Lavery J: A study of the prevalence of eye disease in the elderly in an English community. Trans Ophthalmol Soc UK 1985;104:196-202.
11. Klein BE, Klein R: Cataracts and macular degeneration in older Americans. Arch Ophthalmol 1982; 100:571-573.
12. Martinez GS, Campbell AJ, Remken J, Allan BC: Prevalence of ocular disease in a population study of subjects 65 years old and older. Am J Ophthalmol 1982;94:181-189.
13. Danielsson LG: Incidence of osteoarthritis of the hip. Clin Orthop 1966;45:67.
14. Caird FI, Hutchinson M, Pirie A: Cataract extraction in an English population. Br J Prev Soc Med 1965;19:80-84.
15. Mutch WJ, Dingwall-Fordyce I, Downie AW, Paterson JG, Roy SK: Parkinson's disease in a Scottish city. BMJ 1986;292:534-536.
16. Banerjee AK: The haemopoietic system; in Pathy MSJ (ed): Principles of Geriatric Medicine. Chichester, Wiley, 1985, chap 12.1.
17. Armaly M: Drug mechanisms in glaucoma. London, Churchill, 1966.
18. Mor V: Research and the Ageing Population. Malignant Disease and the Elderly. Chichester, Wiley, 1988.
19. Lerner DJ, Kannel WB: Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population. Am Heart J 1986;111:383-390.
20. Bressler NM. Bressler SB, West SK, Fine SL, Taylor HR: The grading and prevalence of macular degeneration in Cheasapeake Bay watermen. Arch Ophthalmol 1989; 107:847-852.
21. Osterman K, Sprung-Osterman B: Research and the Ageing Population. Chichester, Wiley, 1988.
22. Ritchie K, Kildea D: Is senile dementia 'age-related' or 'ageing-related'? - Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet 1995;346:931-934.
23. Gompertz B: On the nature of the function expressive of the law of human mortality and on a new mode of determining the value of life contingencies. Philos Trans R Soc Lond 1825;A115:513-585.
24. Weale RA: Why has the human visual system evolved in the way it has? Exp Eye Res 1995;60:49-55.
25. Clark R, Zigman S, Lerman S: Studies on the structural proteins of the human lens. Exp Eye Res 1969;8: 172-182.
26. Norn M: Foam in the external part of the eye. Acta Ophthalmol 1987b; 65:143-146.
27. Fisher RF: Elastic constants of the human lens capsule. J Physiol 1969; 201:1-19.
28. Wood AM, Truscott RJW: Ultraviolet filter compounds in human lenses: 3-Hydroxykynurenine glucoside formation. Vision Res 1994;34: 1369-1374.
29. De La Paz MA, Zhang J, Fridowich I: Antioxodiant enzymes of the human retina: Effect of age on enzyme activity of macula and periphery. Curr Eye Res 1996;15:273-278.
30. Lerman S, Borkman RF: A molecular model of lens aging, nuclear and cortical cataract formation. Metab Pediatr Ophthalmol 1979;3:27-35.
31. Wolf E, Bell B, McFarland RA, Podolsky S: Visual perception and communication; in Birren JE, Schaie KW (eds): 'Handbook of the Psychology of Aging'. London, Van Nostrand, 1977.
32. Siebinga I, Vrensen GFJM, Otto K, Puppels GJ, De Mul FFM, Greve J: Age-related changes in local water and protein content of human eye lenses measured by Raman microspectroscopy. Exp Eye Res 1991;53: 233-239.
33. De Roetth A: Lacrimation in normal eyes. Arch Ophthalmol 1953; 49:185-189.
34. Kirchner C: Untersuchungen über das Ausmass der Tränensekretion beim Menschen. Klin Monatsbl Augenheilkd 1964;144:412-417.
35. Broekhuyse RM: Membrane lipids and proteins in ageing lens and cataract; in Elliott K, Fitzsimons DW (eds): The Human Lens - In Relation to Cataract. Ciba Foundation Symposium 19. London, Elsevier, 1973.
36. Harding JJ: Free and protein-bound glutathione in normal and cataractous lenses. Biochem J 1970;117: 957-960.
37. Albon J, Karwatowski WSS, Avery N, Easty D, Duance VC: Changes in the collagenous matrix of the aging human lamina cribrosa. Br J Ophthalmol 1995;79:368-375.
38. Tamm S, Tamm E, Rohen JW: Agerelated changes of the human ciliary muscle. A quantitative morphometric study. Mech Ageing Dev 1992; 62:209-221.
39. Alexandridis E: Iris and Pupillenreaktion im Alter; in Platt D, Hockwin O, Merté H-J (eds): Handbuch der Gerontologie: Augenheilkunde. Stuttgart, Fischer, 1989.
40. Keunen JEE, Van Norren D, Van Meel GJ: Density of foveal pigments at older age. Invest Ophthalmol Vis Sci 1987;28:985-991.
41. Takemoto L: Increase in the intramolecular disulfide bonding of alpha-A-crystallin during aging of the human lens. Exp Eye Res 1996;63: 585-590.
42. Grierson I, Howes RC: Age-related depletion of the cell population in the human trabecular meshwork. Eye 1987;1:204-210.
43. Grunwald JE, Piltz J, Patel N, Bose S, Riva CE: Effect of aging on retinal macular microcirculation: A blue field simulation study. Invest Ophthal Vis Sci 1993;34:3609-3613.
44. Fisher RF: The influence of age on some ocular basement membranes. Eye 1987;1:184-189.
45. Duncan G, Hightower KR, Gandolfi SA, Tomlinson J, Maraini G: Human lens membrane cation permeability increases with age. Invest Ophthalmol Vis Sci 1989;30:1855-1859.
46. Norn M: Expressibility of Meibomian secretion. Acta Ophthalmol 1987;65:137-142.
47. Sawaguchi S, Yue BYJT, Fukuchi T, Iwata K, Kaiya T: Age-related changes of sulfated proteoglycans in the human lamina cribrosa. Curr Eye Res 1993;12:685-692.
48. Balazs EA, Denlinger JL: Aging changes in the vitreus; in Sekuler R, Kline D, Dismukes K (eds): Aging and Human Visual Function New York, Liss, 1982.
49. Duindam JJ, Vrensen GFJM, Otto C, Greve J: Aging affects the conformation of cholesterol in the human eye lens. Ophthalmic Res 1996; 28(suppl):86-91.
50. Laule A, Cable MK. Huffman CE, Hanna C: Endothelial cell population changes of human cornea during life. Arch Ophthalmol 1978;96: 2031-2035.
51. Sato H, Borchman D, Ozaki Y, Lamba OP, Byrdwell WC, Yappert MC, Paterson CA: Lipid-protein interactions in human and bovine lens membranes by Fourier transform Raman and infrared spectroscopies. Exp Eye Res 1996;62:47-53.
52. Boberg-Ans J: Experience in clinical examination of corneal sensitivity. Br J Ophthalmol 1955;39:705-726.
53. Millodot M: The influence of age on the sensitivity of the cornea. Invest Ophthalmol Vis Sci 1977;16:240-242.
54. Pitts DG: The effects of aging on selected visual functions: Dark adaptation, visual acuity, stereopsis, and brightness contrast; in Sekuler R, Kline D, Dismukes K (eds): Aging and Human Visual Function. New York, Liss, 1982.
55. Hochschild R: Improving the precision of biological age determinations 2. Automatic human tests, age norms and variability. Exp Gerontol 1989;24:301-316.
56. Cingle KA, Kalski RS, Bruner WE, O'Brien CM, Erhard P, Wyszynski RE: Age-related changes of glycosidases in human retinal pigment epithelium. Curr Eye Res 1995;15: 433-438.
57. Schmidt SY, Peisch RD: Melanin concentration in normal human retinal pigment epithelium. Invest Ophthalmol Vis Sci 1986;27:1063-1067.
58. Gao H, Hollyfield JG: Aging of the human retina. Invest Ophthalmol Vis Sci 1992;33:1-17.
59. Jonas JB, Schmidt AM, Müller-Bergh JA, Schlötzer-Schrehardt UM, Naumann GOH: Human optic nerve fiber count and optic disc size. Invest Ophthalmol Vis Sci 1992;33: 2012-2018.
60. Weale RA: Human biological decline and mortality rates. Mech Ageing Dev 1997;97:55-72.
61. McNeil D: Epidemiological Research Methods. Chichester, Wiley, 1996.
62. Vingerling JH, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CFL, de Jong PTVM: The prevalence of age-related maculopathy in the Rotterdam study. Ophthalmology 1995;102:205-210.
63. Martinez GS, Campbell AJ, Reinken J. Allan BC: Prevalence of ocular disease in a population study of subjects 65 years old and older. Am J Ophthalmol 1982;94:181-189.
64. Belpoliti M, Rosmini F, Carta A, Ferrigno L, Maraini G: Distribution of cataract types in the Italian-American case-control study and at surgery in the Parma area. Ophthalmology 1995;102:1594-1597.
65. Klein R, Klein BEK, Jensen SC, Meuer SM: The five-year incidence and progression of age-related maculopathy; the Beaver Dam Eye Study of age-related maculopathy. Ophthalmology 1997;104:7-21
66. Leske MC, Chylack LT, Wu SY, Lens Opacities Case-Control Study Group: The lens opacities case-control study. Arch Ophthalmol 1991; 109:244-251.
67. The Italian-American Cataract Study Group, Maraini G: Incidence and progression of cortical, nuclear, and posterior subcapsular cataracts. Am J Ophthalmol 1994;118:623-631.
68. Miglior S, Marighi PE, Musicco M, Balestreri C, Nicolosi A, Orzalesi N: Risk factors for cortical, nuclear, posterior sub-capsular and mixed cataract: A case-control study. Ophthalmic Epidemiol 1994;1:103-105.
69. Sperduto RD, Hiller R: The prevalence of nuclear, cortical, and posterior subcapsular lens opacities in a general population sample. Ophthalmology 1984;91:815-818.
70. Hirvelä H, Luukmen H, Laatikainen L: Prevalence and risk factors of lens opacities in the elderly of Finland. Ophthalmology 1995;102: 108-117.
71. Benson WH, Farber ME, Caplan RJ. Increased mortality rate after cataract surgery. Ophthalmology 1988;95:1288-1292.
72. Hirsch RP, Schwartz B: Increased mortality among elderly patients undergoing cataract extraction. Arch Ophthalmol 1983;101:1034-1037.
73. Minassian DC, Mehra V, Johnson GJ: Mortality and cataract: Findings from a population-based longitudinal study. Bull World Health Organ 1992;70/2:219-223.
74. Thompson JR, Sparrow JM, Gibson JM, Rosenthal AR: Cataract and survival in an elderly nondiabetic population. Arch Ophthalmol 1993; 111:675-679.
75. Podgor MJ, Leske MC, Ederer F: Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retmopathy. Am J Epidemiol 1983;118:206-212.
76. Negrel AD, Minassian DS, Sayek F: Blindness and low vision in south-east Turkey. Ophthalmic Epidemiol 1996;3:127-134.